Christophe Weber

President and CEO
Takeda Pharmaceutical Company Limited

Year of birth: 1966

Christophe Weber is President and Chief Executive Officer of Takeda Pharmaceutical Company Limited. He joined Takeda in April 2014 as Chief Operating Officer, was named President and Representative Director in June 2014, and was subsequently appointed Chief Executive Officer in April 2015.

Mr. Weber has introduced key transformation changes within the global organization which focus on the underlying principles of patient- and customer-centricity, accountability and being as agile as possible for a global company. These critical changes will help secure a strong and sustainable future for Takeda as well as maintain and reinforce the company's core values built over the 230 years of its history.

Mr. Weber has held leadership roles across many different businesses and geographies. Prior to joining Takeda, Mr. Weber held positions of increasing responsibility at GlaxoSmithKline (GSK) including President & General Manager at GSK Vaccines, CEO of GSK Biologicals SA in Belgium, and member of the GSK global Corporate Executive Team. From 2008 to 2010, Mr. Weber served as Asia Pacific SVP and Regional Director at GSK Asia Pacific in Singapore.

Mr. Weber holds a doctorate degree in Pharmacy & Pharmacokinetics from the University of Lyon, France. There, he also earned master’s degrees in Pharmaceutical Marketing and in Accounting and Finance, as well as a bachelor’s degree in statistics.